title: Electrolyte disorders in community subjects: prevalence and risk factors.
abstract: BACKGROUND
  Electrolyte disorders have been studied mainly in hospitalized patients, whereas data in the general population are limited. The aim of this study was to determine the prevalence and risk factors of common electrolyte disorders in older subjects recruited from the general population.
  
  
  METHODS
  A total of 5179 subjects aged 55 years or more were included from the population-based Rotterdam Study. We focused on hyponatremia, hypernatremia, hypokalemia, hyperkalemia, and hypomagnesemia. Multivariable logistic regression was used to study potential associations with renal function, comorbidity, and medication. The adjusted mortality also was determined for each electrolyte disorder.
  
  
  RESULTS
  A total of 776 subjects (15.0%) had at least 1 electrolyte disorder, with hyponatremia (7.7%) and hypernatremia (3.4%) being most common. Diabetes mellitus was identified as an independent risk factor for hyponatremia and hypomagnesemia, whereas hypertension was associated with hypokalemia. Diuretics were independently associated with several electrolyte disorders: thiazide diuretics (hyponatremia, hypokalemia, hypomagnesemia), loop diuretics (hypernatremia, hypokalemia), and potassium-sparing diuretics (hyponatremia). The use of benzodiazepines also was associated with hyponatremia. Hyponatremic subjects who used both thiazides and benzodiazepines had a 3 mmol/L lower serum sodium concentration than subjects using 1 or none of these drugs (P < .001). Hyponatremia and hypomagnesemia were independently associated with an increased mortality risk.
  
  
  CONCLUSIONS
  Electrolyte disorders are common among older community subjects and mainly associated with diabetes mellitus and diuretics. Subjects who used both thiazides and benzodiazepines had a more severe degree of hyponatremia. Because even mild electrolyte disorders were associated with mortality, monitoring of electrolytes and discontinuation of offending drugs may improve outcomes.
authors: Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors: George
authors: G
authors: Liamis
authors: Eline M
authors: EM
authors: Rodenburg
authors: Albert
authors: A
authors: Hofman
authors: Robert
authors: R
authors: Zietse
authors: Bruno H
authors: BH
authors: Stricker
authors: Ewout J
authors: EJ
authors: Hoorn
mesh_terms: D000368:Aged; D048909:Diabetes Complications / Q000453:epidemiology; D004232:Diuretics / Q000009:adverse effects; D005260:Female; D006801:Humans; D053565:Hypercalciuria / Q000453:epidemiology / Q000209:etiology; D006947:Hyperkalemia / Q000453:epidemiology / Q000209:etiology; D006955:Hypernatremia / Q000453:epidemiology / Q000209:etiology; D006973:Hypertension / Q000150:complications / Q000453:epidemiology; D007008:Hypokalemia / Q000453:epidemiology / Q000209:etiology; D007010:Hyponatremia / Q000453:epidemiology / Q000209:etiology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009397:Nephrocalcinosis / Q000453:epidemiology / Q000209:etiology; D009426:Netherlands / Q000453:epidemiology; D015995:Prevalence; D015499:Renal Tubular Transport, Inborn Errors / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects; D014883:Water-Electrolyte Imbalance / Q000139:chemically induced / Q000453:epidemiology* / Q000209:etiology / Q000401:mortality
chemical_list: D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors